Targeted ROMO1 modulation for treating obesity and type 2 diabetes
A novel approach targeting ROMO1, a mitochondrial protein, to treat metabolic disorders. Inhibiting ROMO1 in the liver promotes weight loss, while activating it in pancreatic beta cells supports glucose management, preve...